New directions in CNS drug delivery.
This commentary expands on the above article in 2 ways. First, it provides more recent information on polymer-based drug delivery systems. Second, it discusses experimental systems that may be clinically viable in the future such as prodrugs, cell-polymer transplants and gene transplants.
Langer
R
R
Department of Chemical Engineering, Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139.
Brem
H
H
Langer
L F
LF
D001927:Brain Diseases / Q000188:drug therapy* / Q000601:surgery; D003692:Delayed-Action Preparations; D004343:Drug Implants; D006801:Humans; D009417:Nerve Tissue / Q000637:transplantation; D011108:Polymers
D003692:Delayed-Action Preparations; D004343:Drug Implants; D011108:Polymers